Nicola Williamson

Adelphi Group (United Kingdom) — United Kingdom

Biochemistry, Genetics and Molecular Biology · Life Sciences

10h-index553citations55works7.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Retinal Development and Disorders(7), Retinopathy of Prematurity Studies(5), Hepatitis C virus research(4), Ophthalmology and Visual Impairment Studies(4), Behavioral Health and Interventions(4)

Publications52 total

Exploring the patient experience of chronic hepatitis D (CHD) and assessment of content validity of the Hepatitis Quality of Life Questionnaire and (HQLQv2) and the Fatigue Severity Scale (FSS)
Journal of Patient-Reported Outcomes·2025Open Access
Patient Experience of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): A Qualitative Exploration of Signs, Symptoms, and Health-Related Quality of Life Impacts
Neurology and Therapy·2025· 2 citedOpen Access
Qualitative In-trial Interviews: Methods, Challenges, and Best Practice
Patient·2025· 7 cited
Additional file 2 of Exploring the patient experience of chronic hepatitis D (CHD) and assessment of content validity of the Hepatitis Quality of Life Questionnaire and (HQLQv2) and the Fatigue Severity Scale (FSS)
Figshare·2025Open Access
Additional file 1 of Exploring the patient experience of chronic hepatitis D (CHD) and assessment of content validity of the Hepatitis Quality of Life Questionnaire and (HQLQv2) and the Fatigue Severity Scale (FSS)
Figshare·2025Open Access
The Development and Content Validation of the Sjögren’s Related Quality of Life Instrument (SRQoL)
Rheumatology and Therapy·2024· 3 citedOpen Access
Development and validation of a quality of life and treatment satisfaction measure in canine osteoarthritis
Frontiers in Veterinary Science·2024· 9 citedOpen Access
Qualitative interviews of patients with COPD and muscle weakness enrolled in a clinical trial evaluating a new anabolic treatment: patient perspectives of disease experience, trial participation and outcome assessments
Journal of Patient-Reported Outcomes·2024· 2 citedOpen Access
PCR119 The CaOa-QoL-TS: Development and Validation of an Owner-Completed Health-Related Quality of Life and Treatment Satisfaction Measure in Canine Osteoarthritis
Value in Health·2023
PCR124 Qualitative Exploration of the Patient Experience of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Via Concept Elicitation Interviews with Patients and Neurologists
Value in Health·2023
Qualitative exploration of the visual function impairments and impacts on vision-dependent activities of daily living in Retinitis Pigmentosa and Leber Congenital Amaurosis: content validation of the ViSIO-PRO and ViSIO-ObsRO measures
Journal of Patient-Reported Outcomes·2023· 10 citedOpen Access
Qualitative interviews to assess the impact of chronic hepatitis delta virus infection on health-related quality of life in untreated patients from the US, Italy, Spain, and Germany
Journal of Hepatology·2023
Development of Novel Patient-Reported Outcome (PRO) and Observer-Reported Outcome (ObsRO) Instruments in Retinitis Pigmentosa (RP) and Leber Congenital Amaurosis (LCA): ViSIO-PRO and ViSIO-ObsRO
Ophthalmology and Therapy·2023· 4 citedOpen Access
Psychometric Validation of the ViSIO-PRO and ViSIO-ObsRO in Retinitis Pigmentosa and Leber Congenital Amaurosis
Ophthalmology and Therapy·2023· 4 citedOpen Access
Correction: How strong should my anchor be for estimating group and individual level meaningful change? A simulation study assessing anchor correlation strength and the impact of sample size, distribution of change scores and methodology on establishing a true meaningful change threshold
Quality of Life Research·2023· 5 citedOpen Access
How strong should my anchor be for estimating group and individual level meaningful change? A simulation study assessing anchor correlation strength and the impact of sample size, distribution of change scores and methodology on establishing a true meaningful change threshold
Quality of Life Research·2022· 40 cited
Generation of evidence supporting the content validity of SF-36, FACIT-F, and LupusQoL, and novel patient-reported symptom items for use in patients with systemic lupus erythematosus (SLE) and SLE with lupus nephritis (LN)
Lupus Science & Medicine·2022· 10 citedOpen Access
Cannabis Use and Concern Among Clients Seeking Substance Misuse Treatment: Demographics, Comorbidities, and Service Utilization Patterns Pre-Legalization (2012–2018)
The Canadian Journal of Addiction·2022Open Access
How Strong Should My Anchor Be For Estimating Group And Individual Level Meaningful Change? A Simulation Study Assessing Anchor Correlation Strength And The Impact of Sample Size, Distribution of Change Scores And Methodology On Establishing A True Meaningful Change Threshold.
Research Square (Research Square)·2021· 1 citedOpen Access
Qualitative interviews with patients and caregivers regarding visual function impairments and impacts on vision-dependent activities of daily living and health-related quality of life in RPE65-related Retinitis Pigmentosa and Leber Congenital Amaurosis
Investigative Ophthalmology & Visual Science·2021· 7 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Rob Arbuckle(15), Sophi Tatlock(10), Helena Bradley(9), Claudio Spera(9), Judit Banhazi(9), Joel Sims(8), Melissa Barclay(7), Isabelle Audo(7), Christel Naujoks(7), Francesco Patalano(7), Christine N. Kay(6), Margaret Moffatt(6), Lucy Abraham(6), Adam Gater(5), Todd A. Durham(5), Cheryl Coon(5), Daniel Viriato(5), Bryan Bennett(4), Colin Johnson(4), Doris Staab(4)